Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab. Supplementary data

figure

posted on 2023-05-16, 08:57 authored by Satoru Taguchi, Taketo Kawai, Sebastiano Buti, Melissa Bersanelli, Yukari Uemura, Kenjiro Kishitani, Jimpei Miyakawa, Kazuma Sugimoto, Yu Nakamura, Fusako Niimi, Tomoyuki Kaneko, Jun Kamei, Daisuke Obinata, Kenya Yamaguchi, Shigenori Kakutani, Koichiro Kanazawa, Yuriko Sugihara, Haruki Kume, Satoru Takahashi, Tohru Nakagawa, Hiroshi Fukuhara, Tetsuya Fujimura, Hiroaki Nishimatsu, Yutaka Enomoto, Daisuke YamadaDaisuke Yamada, Yusuke Sato, Yuta Yamada, Yoshiyuki AkiyamaYoshiyuki Akiyama, Mayuko Tokunaga

Supplementary figures 1-5

Supplementary tables 1-3

History

Usage metrics

Keywords

antibiotic urothelial carcinoma proton pump inhibitor pembrolizumab immune checkpoint inhibitor heterogeneity of treatment effect gut microbiome corticosteroid

Licence

CC BY-NC-ND 4.0

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab. Supplementary data

History

Usage metrics

Categories

Keywords

Licence

Exports